Standard: this guide onlyAll-Access Lifetime: all 45 guides + downloadsEducational content only
Glutathione Guide: Available Now
Educational use only — not medical advice. This guide summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.
Glutathione at a glance
What it is
An endogenous tripeptide antioxidant (γ-glutamyl-cysteinyl-glycine), often called the body's 'master antioxidant'
Researched for
Oxidative stress and detoxification support; studied in liver disease, Parkinson's and skin-lightening contexts (investigational, not established)
Commonly reported range
Injectable examples of ~100-600 mg per session; IV protocols in trials ~600-2,000 mg
Route reported
IV, IM or SC injection; also oral, liposomal, sublingual and nebulized forms
Reported frequency
Community examples of 1-3x weekly for injections
Reported cycle
Variable; often cycled in blocks of several weeks with breaks, per community reports
Plasma half-life
Very short after IV — roughly 10-15 minutes for intact GSH in reported pharmacokinetic studies
Regulatory status
Not FDA-approved as an injectable drug; available as a compounded preparation and oral supplement; not a WADA-named substance, though IV infusion volume limits apply
Reported ranges from research/community — examples, not recommendations.
What it is / mechanism
Glutathione (GSH) is a tripeptide composed of glutamate, cysteine and glycine, synthesized in virtually every cell and present at especially high concentrations in the liver. Its reactive cysteine thiol group lets it neutralize reactive oxygen species and electrophiles directly, and it serves as the substrate for the glutathione peroxidase and glutathione-S-transferase enzyme systems central to phase II detoxification. Reduced glutathione (GSH) is recycled from its oxidized form (GSSG) by glutathione reductase, and the GSH:GSSG ratio is widely used as a marker of cellular redox status. When given by injection, intact glutathione is cleared from plasma rapidly and is thought to be broken down to its constituent amino acids, which cells then use to resynthesize glutathione intracellularly. Its reported skin-related effects are attributed in part to inhibition of tyrosinase and a shift toward lighter (pheomelanin) pigment production.
Researched effects
Reported and studied effects include support of antioxidant defense and cellular redox balance, a role in detoxification of xenobiotics and heavy metals, and community-reported use for skin brightening and general wellness. Clinical research has explored glutathione in Parkinson's disease, chronic liver disease, COPD and chemotherapy-associated toxicity, with mixed and often preliminary results. These are research findings and community reports, not guaranteed outcomes, and robust evidence that supplemental or injectable glutathione produces durable clinical benefit in healthy people remains limited.
Evidence & regulatory status
Evidence: Human trials have examined IV and inhaled glutathione in Parkinson's disease, liver disease and COPD; results are generally preliminary or mixed, and reported skin-lightening use rests largely on small studies and anecdote rather than large controlled trials.
Regulatory: Glutathione is not FDA-approved as an injectable drug; injectable forms are supplied as compounded preparations, while oral, liposomal and sublingual products are sold as dietary supplements. It is not individually named on the WADA Prohibited List, but WADA restricts IV infusions/injections exceeding 100 mL per 12-hour period regardless of substance.
Research use: Materials described here are for research and educational purposes only. Nothing here is a recommendation, and injectable use outside a licensed clinical setting is not established as safe or effective.
Dosage — reported ranges (overview)
The figures below are examples of what is reported in the literature and community discussions, not a recommendation or a personal dose. Injectable protocols described in community sources commonly cite roughly 100-600 mg per session given IV, IM or subcutaneously, 1-3 times weekly. Published clinical IV studies have used larger totals, often in the 600-2,000 mg range per infusion for specific investigational indications. Because intact glutathione clears from plasma within minutes, frequency and route vary widely across the sources that report it.
The full step-by-step protocol examples, titration, and printable protocol sheet are planned for a future paid Protocol Playbook module.
Reconstitution — bac-water math
Glutathione is dosed in milligrams, so reconstitution is a concentration calculation. Concentration (mg/mL) equals the vial's total mg divided by the milliliters of bacteriostatic water added; on a U-100 insulin syringe, 100 units = 1 mL. Worked example: a 600 mg vial reconstituted with 3 mL of bacteriostatic water yields 200 mg/mL, so a 200 mg example measure = 200 ÷ 200 = 1 mL = 100 units, and a 100 mg measure = 0.5 mL = 50 units. Add water slowly down the vial wall and swirl gently; never shake. This is concentration math for a representative vial, not a personal dose.
Bac water added
Concentration
200 mg
600 mg
1 mL
600 mg/mL
33 units (0.33 mL)
100 units (1.0 mL)
2 mL
300 mg/mL
67 units (0.67 mL)
200 units (2.0 mL)
3 mL
200 mg/mL
100 units (1.0 mL)
300 units (3.0 mL)
This is concentration math, not a dose recommendation.
Pre-fills example values. Every field remains editable.
The amount printed on the vial or listed on a product page.
mL
Liquid volume used for the concentration calculation.
The mass amount to convert into liquid volume for this math example.
4. Insulin syringe size
Your result
Syringe-unit reading
10 units
= 0.1 mL · 250 mcg target amount
Concentration
2.5mg/mL
Per insulin unit
25mcg
Portions per vial
20
Volume
0.1mL
This calculator is an educational tool for laboratory and research math only. The peptides referenced are research compounds not intended for human or veterinary use, and example values are not medical advice or personal-use instructions. Follow applicable research protocols and regulations.
How the calculator works
Concentration
peptide ÷ liquid
Total peptide divided by liquid volume gives the concentration per mL.
Volume
target ÷ concentration
The target mass divided by concentration gives the liquid volume.
Syringe units
volume × 100
For insulin units, 100 units equals 1 mL, so mL is multiplied by 100.
Worked example: A 5 mg vial plus 2 mL liquid creates a 2.5 mg/mL concentration. A 250 mcg target amount equals 0.1 mL, or 10 insulin units. The vial contains 20 such portions.
Frequently asked questions
How much bacteriostatic water should I enter?+
There is no single calculator-default amount. The liquid volume controls concentration: more liquid creates a less concentrated solution and a larger volume reading for the same target amount; less liquid creates a more concentrated solution and a smaller volume reading.
How do insulin syringe units relate to mL?+
For this math tool, 100 insulin units equals 1 mL, and 1 unit equals 0.01 mL. The 0.3 mL, 0.5 mL, and 1.0 mL options change capacity, not the unit-to-mL relationship.
What is the difference between mg, mcg, and units?+
Milligrams and micrograms measure peptide mass: 1 mg = 1,000 mcg. Syringe units measure liquid volume. Reconstitution math connects mass and volume by using concentration.
Does changing the liquid volume change the total peptide in the vial?+
No. The total peptide amount entered for the vial remains fixed. Changing the liquid volume only changes concentration and the resulting volume shown by the calculator.
Injection / administration basics
In reported protocols, injectable glutathione is prepared with bacteriostatic water and given subcutaneously, intramuscularly or intravenously. Community sources describe rotating SC sites (abdomen, thigh) and using a fresh insulin syringe each time. Glutathione is light- and oxygen-sensitive, so it is typically drawn and used promptly after reconstitution. IV administration is a clinical procedure and is described here only for context, not as a do-it-yourself practice. None of this is medical advice or a personal dosing instruction.
Half-life & frequency rationale
Pharmacokinetic studies report a very short plasma half-life for intact glutathione after IV dosing — on the order of 10-15 minutes (one study reported roughly 14 minutes) — with most of the dose cleared from circulation within minutes. Some sources cite longer apparent half-lives of a few hours when accounting for metabolites and amino-acid recycling. This rapid clearance is a key reason injectable protocols are dosed frequently and why oral bioavailability of intact GSH is debated.
Side effects, safety & contraindications
Reported side effects are generally mild and can include injection-site irritation, a transient sulfur-like taste or smell, headache, or gastrointestinal upset with oral forms. There are case reports and regulatory warnings associating some skin-lightening IV glutathione use with adverse events, and rare hypersensitivity reactions have been described. Human safety data for high-dose and long-term injectable use are limited, and quality/sterility of compounded or research-grade material is a significant concern. This is not a complete safety profile.
Stacking — overview
In community and wellness contexts, glutathione is often combined with other antioxidant or recovery-oriented compounds; these pairings are reported examples, not recommendations, and injectable combinations raise added safety and sterility concerns. It is frequently discussed alongside vitamin C (as a redox partner), NAD+ and repair peptides within our library. The examples below reflect commonly discussed combinations, not endorsements of efficacy or safety.
Recovery & repair
Glutathione + BPC-157 + TB-500 — community-reported alongside tissue-repair peptides for general recovery support
Skin & aesthetics
Glutathione + GHK-Cu — often paired in skin-focused wellness discussions
Longevity & mitochondrial
Glutathione + MOTS-c + SS-31 — grouped in mitochondrial/oxidative-stress-oriented community stacks
Immune support
Glutathione + Thymosin Alpha-1 — discussed together in immune and antioxidant contexts
Storage & handling
Lyophilized (powder) vials are typically stored refrigerated and protected from light and moisture; many sources also cite freezer storage for long-term holding, with room-temperature stability limited.
After reconstitution, glutathione is oxygen- and light-sensitive and is generally kept refrigerated and used within a short window (often cited as up to a few weeks), discarding if discoloration or cloudiness appears.
References
Compiled from reported pharmacokinetic studies (e.g., high-dose IV glutathione trials indexed on PubMed), clinical trial literature, WADA/USADA prohibited-list guidance, and community and compounding-pharmacy dosing summaries; presented for educational use only.
Related peptide guides
Continue exploring related educational guide topics in the Medibact library.
Quick answers about guide scope, access, and educational use context.
Is glutathione a peptide?
It is a tripeptide — three amino acids (glutamate, cysteine, glycine) joined by peptide bonds — but it functions as an antioxidant molecule rather than a signaling peptide. It occurs naturally in nearly all human cells.
Is glutathione FDA-approved or banned in sport?
It is not FDA-approved as an injectable drug; injectable forms are compounded, and oral/sublingual forms are sold as supplements. It is not individually named on the WADA Prohibited List, but WADA prohibits IV infusions exceeding 100 mL per 12-hour period regardless of what is infused.
Why is glutathione dosed so frequently?
Intact glutathione clears from plasma very quickly after IV administration (a reported half-life of roughly 10-15 minutes), which is why reported injectable protocols use frequent dosing and why oral bioavailability of the intact molecule is debated.
How is a 600 mg vial reconstituted?
As concentration math only: 3 mL of bacteriostatic water gives 200 mg/mL, 2 mL gives 300 mg/mL, and 1 mL gives 600 mg/mL. Convert to insulin-syringe units using 100 units = 1 mL. This is not a personal dose.
Does oral glutathione work as well as injections?
The bioavailability of oral intact glutathione is debated because it can be broken down in digestion; liposomal and sublingual forms are marketed to improve this. Evidence on real-world benefit is mixed, and none of this constitutes medical advice.
Compliance and trust notes
Educational content only; no personalized health or outcome claims.
No personalized use recommendation outputs.
Use this material for general learning and research-context literacy.
Educational use only — not medical advice. This guide summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.
